Finance

Lists
NVCT:NASDAQ
Nuvectis Pharma Inc
$21.87
-0.23%
(-0.050) 1D
$21.87
0.00% (0.00)
After hours
Closed: Sep 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
$21.84
High
$22.41
Low
$21.31
Mkt. cap
712.56M
Avg. vol.
202.57K
Volume
0.00
52-wk high
$29.28
52-wk low
$5.55
EPS
-$1.31
Beta
-0.26
Shares outstanding
32.64M
No. of employees
16
Open
$21.84
High
$22.41
Low
$21.31
Mkt. cap
712.56M
Avg. vol.
202.57K
Volume
0.00
52-wk high
$29.28
52-wk low
$5.55
EPS
-$1.31
Beta
-0.26
Shares outstanding
32.64M
No. of employees
16
News stories
From web sources and news partners
About Nuvectis Pharma Inc
CEO-
Employees16
Founded2020
HeadquartersFort Lee, New Jersey, United States
SectorBiotechnology
Websitenuvectis.com
Analyst ratings
Based on 5 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current $21.87
$39.00 (+78.33%)
Average
$34.00 (+55.46%)
Lowest
$30.00 (+37.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$30.00
+37.2%
08/05/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$34.00
+55.5%
08/05/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$39.00
+78.3%
08/04/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
$33.00
+50.9%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
$20.00
-8.6%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.77M
5.09M
4.11M
4.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.02M
2.53M
2.15M
2.51M
Operating expense
7.79M
7.62M
6.26M
7.20M
Total operating expenses
7.79M
7.62M
6.26M
7.20M
Operating income
-7.79M
-7.62M
-6.26M
-7.20M
Other non operating income
-
-
-
-
EBT including unusual items
-7.46M
-7.31M
-6.05M
-7.02M
EBT excluding unusual items
-7.46M
-7.31M
-6.05M
-7.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.46M
-7.31M
-6.05M
-7.02M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
332.00K
303.00K
210.00K
177.00K
Interest expense
-
-
-
-
Net interest expenses
332.00K
303.00K
210.00K
177.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps